Vancive Medical Technologies in antimicrobial dressing collaboration

Vancive Medical Technologies has teamed up with Eloquest Healthcare on a line of transparent post-operative dressings designed to enhance patient care. The device has received 510(k) clearance from the FDA.

The new dressings, called ReliaTect, incorporate BeneHold CHG, an innovative adhesive technology from Vancive that comfortably secures the dressing to the skin, absorbs fluids and protects the site from external contaminants. The CHG contained within the adhesive preserves the dressings from microbial growth, making them ideally suited for post-operative sites. Eloquest Healthcare is the exclusive distributor of the dressings in the United States and Canada.